Addiction Medicine: Beyond The Abstract

Journal of Addiction Medicine Journal of Addiction Medicine. 14(5):401-408, September/October 2020 In episode eighteen of Addiction Medicine: Beyond the Abstract, we are joined by Kimberly Spence, MD. She is an Associate Professor of Pediatrics at the Saint Louis University School of Medicine. In her paper, Dr. Spence discusses the benefits of treating neonates with Neonatal Opioid Withdrawal Syndrome (NOWS) on the mother-baby unit rather than admitting them to the NICU.

Journal of Addiction Medicine  In episode seventeen of Addiction Medicine: Beyond the Abstract, we are joined by Kathleen Carroll, PhD. She is the Albert E. Kent Professor of Psychiatry at Yale University School of Medicine. In her paper, Dr. Carroll discusses the feasibility of implementing computer-based treatments for substance use disorders in primary care settings.

In episode sixteen of Addiction Medicine: Beyond the Abstract, we are joined by Itai Danovitch, MD, MBA. He is the chairman of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles. In his paper, Dr. Danovitch discusses some of the challenges facing the study of opioid overdose events in the hospital setting.   To learn more, click here.

In episode fifteen of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Tricia Wright, MD, MS, FACOG, DFASAM. She is a professor of clinical medicine at the University of California San Francisco. In her recent commentary, Dr. Wright discusses some of the challenges facing women in opioid treatment programs and the need for the provision of reproductive healthcare to this population. To learn more, click here.  

In episode fourteen of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Babak Tofighi. He is an assistant professor in the departments of medicine and population health at the NYU School of Medicine. In his recent article, Dr. Tofighi discusses the use of technology-based interventions to optimize the treatment of substance use disorders (SUDs) and related comorbidities. To read more, click here.      

In episode thirteen of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Jessica Gray. She is a family medicine physician and an addiction specialist in the departments of Medicine at Massachusetts General Hospital (MGH) and Pediatrics at Massachusetts General Hospital for Children (MGHfC). She is also Associate Program Director for the MGH Addiction Medicine Fellowship and Clinical Director of the HOPE Clinic at MGH. In her recent article, Dr. Gray discusses a case of a woman who was able to continue opioid agonist treatment during the postpartum period while she remained incarcerated, in a system that generally did not allow for opioid agonist treatment during incarceration except during pregnancy. To learn more, click here. 

In episode twelve of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Hendrée Jones, a professor in the Department of Obstetrics and Gynecology at the University of North Carolina and the Director of UNC Horizons Program. In her recent article, Dr. Jones and her colleagues discuss the treatment of women in opioid use treatment programs in North Carolina and their utilization of reproductive and sexual health services.  To read the article, click here.  

In episode eleven of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Honora Englander, an Associate Professor of Medicine at Oregon Health & Science University and the Director and Principal Investigator of the Improving Addiction Care Team (IMPACT). In her recent article, Dr. Englander and her colleagues discuss using hospitalization as a "reachable moment" for highly vulnerable patients who are not engaged in treatment elsewhere and utilizing the IMPACT team in this process.    To read more, click here.

In episode ten of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Caleb Banta-Green, principal research scientist at The Alcohol and Drug Abuse Institute at the University of Washington. In his recent study, Dr. Banta-Green and his colleagues surveyed syringe exchange program (SEP) clients to gauge interest in receiving help with cessation or reduction of opiate use. Data from this study produced valuable conclusions about subgroups that are more likely to take advantage of available interventions.   Read more here.